1. Home
  2. INAB vs PSHG Comparison

INAB vs PSHG Comparison

Compare INAB & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • PSHG
  • Stock Information
  • Founded
  • INAB 2016
  • PSHG 2010
  • Country
  • INAB United States
  • PSHG Greece
  • Employees
  • INAB N/A
  • PSHG N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • PSHG Marine Transportation
  • Sector
  • INAB Health Care
  • PSHG Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • PSHG Nasdaq
  • Market Cap
  • INAB 24.0M
  • PSHG 20.3M
  • IPO Year
  • INAB 2021
  • PSHG N/A
  • Fundamental
  • Price
  • INAB $0.24
  • PSHG $1.74
  • Analyst Decision
  • INAB Strong Buy
  • PSHG Strong Buy
  • Analyst Count
  • INAB 3
  • PSHG 1
  • Target Price
  • INAB $7.75
  • PSHG $6.50
  • AVG Volume (30 Days)
  • INAB 750.7K
  • PSHG 80.0K
  • Earning Date
  • INAB 11-12-2024
  • PSHG 11-07-2024
  • Dividend Yield
  • INAB N/A
  • PSHG N/A
  • EPS Growth
  • INAB N/A
  • PSHG N/A
  • EPS
  • INAB N/A
  • PSHG 1.51
  • Revenue
  • INAB N/A
  • PSHG $89,608,000.00
  • Revenue This Year
  • INAB N/A
  • PSHG N/A
  • Revenue Next Year
  • INAB N/A
  • PSHG $1.85
  • P/E Ratio
  • INAB N/A
  • PSHG $1.17
  • Revenue Growth
  • INAB N/A
  • PSHG N/A
  • 52 Week Low
  • INAB $0.22
  • PSHG $1.61
  • 52 Week High
  • INAB $1.93
  • PSHG $2.58
  • Technical
  • Relative Strength Index (RSI)
  • INAB 38.43
  • PSHG 49.82
  • Support Level
  • INAB $0.23
  • PSHG $1.82
  • Resistance Level
  • INAB $0.32
  • PSHG $1.96
  • Average True Range (ATR)
  • INAB 0.03
  • PSHG 0.12
  • MACD
  • INAB -0.01
  • PSHG 0.01
  • Stochastic Oscillator
  • INAB 10.62
  • PSHG 51.43

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About PSHG Performance Shipping Inc.

Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates eight Aframax tanker vessels.

Share on Social Networks: